Compare CHR & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHR | ACON |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 4.4M |
| IPO Year | N/A | 2022 |
| Metric | CHR | ACON |
|---|---|---|
| Price | $0.04 | $6.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 60.7M | 61.7K |
| Earning Date | 07-30-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.92 | N/A |
| Revenue | ★ $147,134,000.00 | $67,483.00 |
| Revenue This Year | N/A | $145.39 |
| Revenue Next Year | N/A | $145.45 |
| P/E Ratio | $0.02 | ★ N/A |
| Revenue Growth | N/A | ★ 36.91 |
| 52 Week Low | $0.03 | $5.55 |
| 52 Week High | $2.97 | $3,499.49 |
| Indicator | CHR | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 29.21 | 48.03 |
| Support Level | $0.04 | $5.71 |
| Resistance Level | $0.06 | $6.89 |
| Average True Range (ATR) | 0.01 | 0.61 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 34.95 | 35.04 |
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.